| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Illumina, Inc. (ILMN) has 12 insiders with recent SEC Form 4 filings, including 0 buys and 16 sells. ILMN is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 3.50M | $565.17M | - | |
| Dir | 2.83M | $456.78M | -669,596 | |
| CEO | 82.1K | $13.25M | - | |
| VP | 41.9K | $6.77M | - | |
| VP | 33.0K | $5.33M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Dec 2, 2019 | Van Oene Mark79 | SVP Chief Commercial Officer | Sell | 625 | $320.15 | $200,093.75 | -5.0% | |
| Nov 29, 2019 | Samad Sam | SVP And CFO | Sell | 892 | $320.00 | $285,440.00 | -20.5% | |
| Nov 14, 2019 | Febbo Phillip G.63 | SVP Chief Medical Officer | Sell | 155 | $300.00 | $46,500.00 | -9.3% | |
| Nov 1, 2019 | Dadswell Charles82 | SVP &General Counsel | Sell | 193 | $297.28 | $57,375.04 | -3.7% | |
| Nov 1, 2019 | Van Oene Mark79 | SVP Chief Commercial Officer | Sell | 625 | $300.10 | $187,562.50 | -4.4% | |
| Nov 1, 2019 | Ragusa Robert P | SVP, Global Quality &Ops | Sell | 1,674 | $297.28 | $497,646.72 | -14.1% | |
| Oct 15, 2019 | Ronaghi Mostafa | SVP &CTO | Sale+OE | 4,000 | $310.93 | $1,243,710.68 | -1.3% | |
| Oct 1, 2019 | Van Oene Mark79 | SVP Chief Commercial Officer | Sell | 625 | $304.84 | $190,525.00 | -4.2% | |
| Oct 1, 2019 | Dadswell Charles82 | SVP &General Counsel | Sell | 124 | $304.22 | $37,723.28 | -2.3% | |
| Sep 16, 2019 | Ronaghi Mostafa | SVP &CTO | Sale+OE | 10,000 | $300.53 | $3,005,322.89 | -3.0% |